Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Vignon
Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
Clinical Cancer Research
Cancer Research
Oncology
Related publications
MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
The Dual PI3K/mTOR Inhibitor, NVP-BEZ235, Is Efficacious Against Follicular Lymphoma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Efficacy of the Dual PI3K and mTOR Inhibitor NVP-BEZ235 in Combination With Imatinib Mesylate Against Chronic Myelogenous Leukemia Cell Lines
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Nab-Paclitaxel Antitumor Response in Experimental Gastric Cancer
International Journal of Oncology
Cancer Research
Oncology
NVP-BEZ235, a Novel Dual PI3K/mTOR Inhibitor, Enhances the Radiosensitivity of Human Glioma Stem Cells in Vitro
Acta Pharmacologica Sinica
Medicine
Pharmacology
Specific Apoptosis Induction by the Dual PI3K/mTor Inhibitor NVP-BEZ235 in HER2 Amplified and PIK3CA Mutant Breast Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Therapeutic Potentials of İnhibition Jumonji C Domain Containing Demethylases in Acute Myeloid Leukemia
Turkish Journal of Haematology
Hematology
Dual Roles of EZH2 in Acute Myeloid Leukemia
Journal of Experimental Medicine
Medicine
Allergy
Immunology